FDA Inspection 1082326 — AlloSource
The FDA completed an inspection of AlloSource on March 6, 2019 in Maryland Heights, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 6, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Maryland Heights, MO (United States)